Inhibiting the expression of miR-135a in C2C12 myoblasts can increase the expression levels of IRS2 and Akt in C2C12 myoblasts, improve glucose tolerance, and reduce the symptoms of hyperglycemia [31]. The gene discussed is IRS2; the disease is Hyperglycemia.